Top compounds associated with response to CTD-2021K4.1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.073 0.04
mRNA BRD-K27224038 CTRPv2 pan-cancer AAC 0.15 0.04
mRNA BRD-K84807411 CTRPv2 pan-cancer AAC 0.15 0.04
mRNA isoevodiamine CTRPv2 pan-cancer AAC 0.069 0.04
mRNA nelarabine CTRPv2 pan-cancer AAC -0.081 0.04
mRNA PD 153035 CTRPv2 pan-cancer AAC -0.091 0.04
mRNA CIL56 CTRPv2 pan-cancer AAC 0.093 0.04
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.04
mRNA SN-38 CTRPv2 pan-cancer AAC 0.076 0.04
mRNA Gefitinib CTRPv2 pan-cancer AAC -0.074 0.05
Download CSV